Eliem Therapeutics agrees to acquire Tenet

Eliem Therapeutics has announced an agreement for the acquisition of development-stage private biotechnology company Tenet Medicines.

Apr 13, 2024 - 00:00

Eliem Therapeutics agrees to acquire Tenet

Eliem Therapeutics has announced an agreement for the acquisition of development-stage private biotechnology company Tenet Medicines.

Read the original article

Tags:

Previous Article

Fujifilm invests $1.2bn ramping up North Carolina facility

Novartis signs deal for Arvinas’ prostate cancer therapy

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Sandoz partners with Samsung Bioepis to license Stelara biosimilar

Sandoz partners with Samsung Bioepis to license Stelara...

Sep 11, 2023

Opzelura by Incyte for Chronic Cutaneous Lupus Erythema...

May 17, 2024

FDA advisory panel recommends a streamlined flu vaccine for next fall

FDA advisory panel recommends a streamlined flu vaccine...

Mar 6, 2024